NCT04924348 is a NA clinical trial of Experimental: WALANT procedure in Carpal Tunnel, sponsored by Elsan.

Who is sponsoring NCT04924348?

NCT04924348 is sponsored by Elsan.

What drugs are being tested in NCT04924348?

Interventions in NCT04924348: Experimental: WALANT procedure, Active Comparator: Axial ALR, Active Comparator: Truncal ALR.

What condition does NCT04924348 study?

NCT04924348 studies Carpal Tunnel, Median Nerve Neuralgia, Anesthesia, Local.

Is NCT04924348 still recruiting?

NCT04924348 is currently completed. Last updated 10 March 2023.

Last reviewed 2023-03-10 · How we verify

NCT04924348

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

WALANT Procedure in Carpal Tunnel Release

Completed NA Last updated 10 March 2023

What this trial tests

NA trial testing Experimental: WALANT procedure in Carpal Tunnel in 144 participants. Completed in 25 January 2023.

Timeline

2 December 2020

Primary endpoint
15 February 2022

25 January 2023

Quick facts

Lead sponsor	Elsan
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	144
Start date	2 December 2020
Primary completion	15 February 2022
Estimated completion	25 January 2023
Sites	1 location across France

Drugs / interventions tested

Experimental: WALANT procedure
Active Comparator: Axial ALR
Active Comparator: Truncal ALR

Conditions studied

Carpal Tunnel — all drugs for Carpal Tunnel →
Median Nerve Neuralgia — all drugs for Median Nerve Neuralgia →
Anesthesia, Local — all drugs for Anesthesia, Local →

Sponsor

Elsan — full company profile →

Who can join

Adults 18 to 99, any sex, with Carpal Tunnel or Median Nerve Neuralgia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The possible benefits expected from the use of the WALANT procedure are a decrease in intraoperative pain at the surgical site, a decrease in hospitalization time, and a decrease in the time required to lift the anesthesia postoperatively. The risks identified are those inherent to each type of anesthesia (WALANT or traditional ALR), as encountered in current practice, and are therefore not specific to the study: risks related to the local anesthetic agent or risks related to the puncture procedure. The main objective is to determine whether the patient's intraoperative pain at the surgical site is less after a WALANT procedure compared to a traditional ALR procedure (axillary or trunk).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Carpal Tunnel

Currently open trials in the same condition.

NCT06133712 — Dexmedetomidine, Ozone and Dexamethasone Local Injection in Carpal Tunnel Syndrome for Pain Relief · NA · recruiting
NCT04460521 — The ACTS Trial: N-acetylcysteine (NAC) and Night-splinting as a Non-operative Treatment for Carpal Tunnel Syndrome · Phase 4 · recruiting

Other Elsan trials

Trials by the same sponsor.

NCT07464665 — Comparing Dual-mobility Cups Versus Unipolar Cups for Unselected Primary Total Hip Arthroplasty by Direct Anterior Appro · NA · not yet recruiting
NCT07267572 — Evaluation of the Added Value of Logotherapy in the Psychological Support of Patients With Primary Breast Cancer · NA · not yet recruiting
NCT07248124 — Pilot Study, Aimed at Describing in Myography, the Collapse of the Muscular Response Visualized in the Scratch Collapse · NA · recruiting
NCT06835790 — Comparative 3-year Study of Nissen-sleeve vs. Sleeve Plus Cruroplasty in Obese Patients With Hiatal Hernia · NA · not yet recruiting
NCT06822452 — Prospective Comparative Study Evaluating the Early Complications of Robot-assisted Radical Prostatectomy Performed as an · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04924348 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Elsan
Last refreshed: 10 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04924348.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing